Study of SYS6020 in BCMA-positive Multiple Myeloma

Conditions: Multiple Myeloma Interventions: Biological: BCMA Targeted CAR T-cells Sponsors: Wuhan Union Hospital, China Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials